Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study KK Kumarasamy, MA Toleman, TR Walsh, J Bagaria, F Butt, ... The Lancet infectious diseases 10 (9), 597-602, 2010 | 4146 | 2010 |
Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases S Mushtaq, S Irfan, JB Sarma, M Doumith, R Pike, J Pitout, DM Livermore, ... Journal of antimicrobial chemotherapy 66 (9), 2002-2005, 2011 | 217 | 2011 |
Prevalence of blaTEM, blaSHV and blaCTX-M genes in clinical isolates of Escherichia coli and Klebsiella pneumoniae from Northeast India A Bora, NK Hazarika, SK Shukla, KN Prasad, JB Sarma, G Ahmed Indian journal of Pathology and Microbiology 57 (2), 249-254, 2014 | 95 | 2014 |
Co-morbidities as predictors of mortality in Clostridium difficile infection and derivation of the ARC predictive score MR Welfare, LC Lalayiannis, KE Martin, S Corbett, B Marshall, JB Sarma Journal of Hospital Infection 79 (4), 359-363, 2011 | 82 | 2011 |
Multidrug-resistant Enterobacteriaceae including metallo-β-lactamase producers are predominant pathogens of healthcare-associated infections in an Indian teaching hospital JB Sarma, PK Bhattacharya, D Kalita, M Rajbangshi Indian journal of medical microbiology 29 (1), 22-27, 2011 | 76 | 2011 |
Daptomycin for the treatment of osteomyelitis and orthopaedic device infections: real-world clinical experience from a European registry K Malizos, J Sarma, RA Seaton, M Militz, F Menichetti, G Riccio, ... European Journal of Clinical Microbiology & Infectious Diseases 35, 111-118, 2016 | 60 | 2016 |
Effects of fluoroquinolone restriction (from 2007 to 2012) on Clostridium difficile infections: interrupted time-series analysis JB Sarma, B Marshall, V Cleeve, D Tate, T Oswald, S Woolfrey Journal of Hospital Infection 91 (1), 74-80, 2015 | 55 | 2015 |
Effects of fluoroquinolone restriction (from 2007 to 2012) on resistance in Enterobacteriaceae: interrupted time-series analysis JB Sarma, B Marshall, V Cleeve, D Tate, T Oswald, S Woolfrey Journal of Hospital Infection 91 (1), 68-73, 2015 | 51 | 2015 |
Thirty-day mortality of Clostridium difficile infection in a UK National Health Service Foundation Trust between 2002 and 2008 AP McGowan, LC Lalayiannis, JB Sarma, B Marshall, KE Martin, ... Journal of Hospital Infection 77 (1), 11-15, 2011 | 49 | 2011 |
Incidence of blaNDM-1 gene in Escherichia coli isolates at a tertiary care referral hospital in Northeast India A Bora, GU Ahmed, NK Hazarika, KN Prasad, SK Shukla, V Randhawa, ... Indian journal of medical microbiology 31 (3), 250-256, 2013 | 47 | 2013 |
Infection control with limited resources: why and how to make it possible? JB Sarma, GU Ahmed Indian Journal of Medical Microbiology 28 (1), 11-16, 2010 | 45 | 2010 |
Characterisation of methicillin resistant S. aureus strains and risk factors for acquisition in a teaching hospital in northeast India JB Sarma, GU Ahmed Indian Journal of Medical Microbiology 28 (2), 127-129, 2010 | 44 | 2010 |
Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORESM Registry A Gonzalez-Ruiz, P Gargalianos-Kakolyris, A Timerman, J Sarma, ... Advances in Therapy 32, 496-509, 2015 | 33 | 2015 |
Prevalence and risk factors for colonisation with extended spectrum β-lactamase producing enterobacteriacae vis-à-vis usage of antimicrobials JB Sarma, GU Ahmed Indian Journal of Medical Microbiology 28 (3), 217-220, 2010 | 16 | 2010 |
Synthesis, characterization and in vitro antimicrobial evaluation of some novel benzimidazole derivatives bearing hydrazone moiety J Sarma, G Singh, M Gupta, R Gupta, B Kapoor Asian J. Pharm. Clin. Res 10, 1-6, 2017 | 10 | 2017 |
Risk Factors for Mortality in Patients With Clostridium difficile Infection To the Editor—We read with great interest the recent article by Morrison R Huttunen, J Aittoniemi, S Corbett, B Marshall, JB Sarma infection 170, 784-90, 2010 | 10 | 2010 |
Antibiotic Stewardship und Hygiene–2 Seiten einer Medaille P Gastmeier AINS-Anästhesiologie· Intensivmedizin· Notfallmedizin· Schmerztherapie 52 …, 2017 | 7 | 2017 |
Impact of universal screening on MRSA bacteremias in a single acute NHS organisation (2006–12): interrupted time-series analysis JB Sarma, B Marshall, V Cleeve, D Tate, T Oswald Antimicrobial resistance and infection control 2, 1-11, 2013 | 7 | 2013 |
New Delhi metallo-β-lactamase 1–Authors' reply TR Walsh, MA Toleman, JB Sarma, S Irfan, N Woodford, DM Livermore The Lancet Infectious Diseases 10 (11), 752-754, 2010 | 7 | 2010 |
Identifying Antibiotic Use Targets for the Management of Antibiotic Resistance Using an Extended-Spectrum β-Lactamase-Producing Escherichia coli Case: A … MA Aldeyab, SE Bond, BR Conway, J Lee-Milner, JB Sarma, WJ Lattyak Antibiotics 11 (8), 1116, 2022 | 6 | 2022 |